A CEST MRI method detects lactate in vivo by comparing lactate maps before and after administering a metabolic precursor contrast agent.
A CEST MRI method measures tumor glutaminase expression by comparing glutamate maps before and after glutamine or glutaminase blocker injection.
The technology measures multiple circulating biomarkers and applies machine learning to diagnose disease, classify stage, and assess therapy response.
The technology uses non-nutritive sweeteners or polyols as imaging agents for MRI and PET detection of tissue accumulation.
Magnetic pore filters in microfluidic devices enable capture, release, and analysis of magnetically tagged particles, including cells and exosomes.
The technology combines human ultrasound assessment with automatically extracted image features to classify malignancy risk and flag low-confidence cases for further evaluation.
[%brief%]
Molecular diagnostic using clamping fluorescent probes to amplify RNA detection signal of single-cell assay
Leveraging open-source AI platforms, this technology enables automated image-based detection, prediction, and control of microfluidic single bubble/droplet formation.
A quick and inexpensive method to detect cancer early by exponentially amplifying rare and scarce cancer mutations.